Type 2 diabetes Diabetes mellitus type 2
Conditions
Interventions
Intervention is the use of CGM using glucose sensor technology in the period prior to hospitalization. In the control group participants will wear a blinded CGM and will continue usual care for glucos
Sponsors
Isala
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Type 2 diabetesHbA1c > 53 mmol/molScheduled for orthopedic surgery (knee or hip arthroplasty)
Exclusion criteria
Exclusion criteria: Use of a basal-bolus insulin (i.e. 4 times a day insulin injections consisting of a basal and 3 times a bolus insulin) schedule Need for urgent orthopedic surgery i.e. within the next 6 weeksPrevious experience longer than 3 consecutive months with CGM devicesCurrent or planned pregnancy Use of parenteral feeding regimens.Any general diseases or mental disorder rendering participation in the study impossibleDrug abuse Insufficient mastery of the Dutch language
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoint is the difference in TIR (time in mean range) over the five days prior to surgery between the two groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome include (differences in) effectiveness (amongst others measures of glycemic control, hospitalization outcomes, lifestyle and self-management), implementation / process evaluation, patient reported outcomes and cost-effectiveness. | — |
Countries
Netherlands
Contacts
Public ContactP.R. van Dijk
Isala
Outcome results
None listed